Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liaoning Huarui Union Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of high-end generic and innovative injectable drugs. The company focuses primarily on therapeutic areas such as cardiovascular and cerebrovascular diseases, anti-infectives, and metabolic disorders. It is well-known for its expertise in complex formulations, particularly lipid emulsions and liposomal drug delivery systems. Huarui Union operates large-scale manufacturing facilities in Shenyang and maintains a robust portfolio of products approved by the NMPA. The company is recognized as a National High-tech Enterprise and plays a significant role in the domestic supply of critical care medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liaoning Huarui Union Pharmaceutical.